Note to File Podcast - Episode 41: Jane Myles, VP Innovation at Curebase
March 29, 2022
Jane is a self-proclaimed clinical trial operations nerd. She’s had the opportunity to work on global drug development programs across many therapeutic areas but calls Hematology/Oncology her TA home base. Jane switched from molecule focus to portfolio focus about 12 years ago, first focused on patient recruitment, then patient voice and input, then patient facing technology and it's adoption. She’s able to merge them all together in her current role as VP Innovation at Curebase, building DCT technology and services to drive access and inclusion to trials.
In this episode, Jane and Brad discuss the tall order of standardizing definitions in decentralized clinical trials, the role of sites in technology adoption, Jane’s role with DTRA, lessons learned from the beach, and so much more.
At Curebase, our mission is to bring quality medical innovations to patients faster and improve human wellbeing through more efficient clinical studies. We are proving that clinical research can be radically accelerated if we empower physicians everywhere to enroll patients in the communities where they live. By applying cutting edge clinical software and remote study management techniques to the problem, we are reinventing clinical trials and research from the ground up.
SOURCE Note to File Podcast